{"id":"NCT00575094","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects","officialTitle":"A Phase 3, Multicenter, Open-label Study Evaluating the Safety and Efficacy of Intravenous Tigecycline to Treat Hospitalized Japanese Subjects With Community-acquired Pneumonia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2008-03","completion":"2008-03","firstPosted":"2007-12-17","resultsPosted":"2009-05-27","lastUpdate":"2011-06-03"},"enrollment":9,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Community-Acquired Infections"],"interventions":[{"type":"DRUG","name":"tigecycline","otherNames":[]}],"arms":[],"summary":"To purpose of this study is to assess the safety and tolerability of intravenous (IV) tigecycline in hospitalized subjects of Japanese descent with community-acquired pneumonia (CAP).","primaryOutcome":{"measure":"Number of Patients by Clinical Response at Test-of-Cure (TOC) Visit.","timeFrame":"8 weeks","effectByArm":[{"arm":"Tigecycline","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":9,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Nausea","Diarrhea","Vomiting","Stomach Disorder","Alanine aminotransferase increased"]}}